Analyst Consensus ?
ConsensusBuy50 ratings
Bullish2652.0%
Neutral2346.0%
Bearish12.0%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
The Procter & Gamble Company complete analyst coverage
The Procter & Gamble Company (PG) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$148.63Previous close
$40Low
$161.03Average
$192High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Jul 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 21, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 16, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 10, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 27, 2026 |
| UBS | Buy | Buy | Maintain | Apr 27, 2026 |
| TD Cowen | Hold | Hold | Maintain | Apr 27, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Apr 27, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Apr 8, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 30, 2026 |
| Jefferies | Buy | Hold | Upgrade | Dec 17, 2025 |
| Freedom Broker | Hold | Hold | Maintain | Oct 29, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Oct 20, 2025 |
| BNP Paribas | Outperform | Outperform | Maintain | Aug 15, 2025 |
| Truist Securities | Buy | Buy | Maintain | Apr 25, 2025 |
| RBC Capital | Outperform | Sector Perform | Upgrade | Apr 25, 2025 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 25, 2025 |
| Citigroup | Buy | Buy | Maintain | Apr 25, 2025 |
| Stifel | Hold | Hold | Maintain | Jan 23, 2025 |
| DA Davidson | Buy | Buy | Maintain | Jan 23, 2025 |
| DZ Bank | Buy | Hold | Upgrade | Aug 29, 2024 |
| Argus Research | Buy | Buy | Maintain | Apr 25, 2024 |
| Bernstein | Market Perform | Market Perform | Maintain | Oct 12, 2023 |
| Wolfe Research | Outperform | Outperform | Maintain | Nov 22, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Nov 15, 2022 |
| Goldman Sachs | Neutral | Buy | Downgrade | Oct 10, 2022 |
| Independent Research | Buy | Hold | Upgrade | Jan 22, 2021 |
| Berenberg | Hold | Sell | Upgrade | Jan 24, 2019 |
| Bank of America | Buy | Buy | Maintain | Jan 8, 2019 |
| Macquarie | Outperform | Outperform | Maintain | Oct 22, 2018 |
| Atlantic Equities | Overweight | Overweight | Maintain | Sep 20, 2018 |
| B. Riley FBR | Neutral | Buy | Downgrade | May 5, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Apr 20, 2018 |
| Argus | Hold | Buy | Downgrade | Apr 20, 2018 |
| B. Riley Securities | Neutral | Buy | Downgrade | Mar 6, 2017 |
| SunTrust Robinson Humphrey | Hold | Buy | Downgrade | Dec 22, 2016 |
| CLSA | Outperform | Outperform | Maintain | Oct 26, 2016 |
| Argus Capital | Buy | Hold | Upgrade | Oct 12, 2016 |
| Johnson Rice | Buy | Accumulate | Maintain | Aug 26, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Feb 16, 2016 |
| Sterne Agee | Buy | Neutral | Upgrade | Feb 16, 2016 |
| GMP Securities | Hold | Hold | Maintain | Feb 3, 2016 |
| Hilliard Lyons | Neutral | Upgrade | Jun 4, 2015 | |
| Societe Generale | Hold | Buy | Downgrade | Apr 29, 2015 |
| BTIG Research | Neutral | Neutral | Maintain | Dec 30, 2014 |
| Canaccord Genuity | Hold | Buy | Downgrade | Nov 17, 2014 |
| Standpoint Research | Hold | Sell | Upgrade | Jan 31, 2014 |
| Exane BNP Paribas | Underperform | Underperform | Maintain | Sep 11, 2013 |
| Oracle Investment Research | Hold | Sell | Upgrade | May 24, 2013 |
| Tigress Financial | Neutral | Neutral | Maintain | Feb 25, 2013 |
| BMO Capital | Outperform | Outperform | Maintain | Oct 26, 2012 |
| Bank oferica | Buy | Buy | Maintain | Feb 28, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $148.63. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $152 | $149.14 | +2.3% | Jul 21, 2026 |
| Bernstein | Analyst unavailable | $156 | $148.32 | +5.0% | Jun 11, 2026 |
| UBS | Analyst unavailable | $172 | $148.46 | +15.7% | Apr 27, 2026 |
| Deutsche Bank | Steve Powers | $163 | $148.63 | +9.7% | Apr 27, 2026 |
| Evercore ISI | Robert Ottenstein | $162 | $148.11 | +9.0% | Apr 27, 2026 |
| Wells Fargo | Analyst unavailable | $164 | $148.11 | +10.3% | Apr 27, 2026 |
| Barclays | Analyst unavailable | $146 | $143.86 | -1.8% | Apr 14, 2026 |
| RBC Capital | Analyst unavailable | $167 | $146.66 | +12.4% | Apr 9, 2026 |
| Piper Sandler | Analyst unavailable | $142 | $144.9 | -4.5% | Apr 8, 2026 |
| Wells Fargo | Analyst unavailable | $177 | $160.07 | +19.1% | Feb 17, 2026 |
| UBS | Analyst unavailable | $170 | $151.06 | +14.4% | Jan 23, 2026 |
| Wells Fargo | Chris Carey | $165 | $149.93 | +11.0% | Jan 23, 2026 |
| Barclays | Lauren Lieberman | $155 | $144.37 | +4.3% | Jan 16, 2026 |
| UBS | Peter Grom | $161 | $146.54 | +8.3% | Jan 14, 2026 |
| Piper Sandler | Analyst unavailable | $150 | $139.91 | +0.9% | Jan 7, 2026 |
| Wells Fargo | Analyst unavailable | $158 | $140.04 | +6.3% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $179 | $145.21 | +20.4% | Dec 16, 2025 |
| Barclays | Analyst unavailable | $151 | $143.45 | +1.6% | Dec 8, 2025 |
| Morgan Stanley | Analyst unavailable | $175 | $151.46 | +17.7% | Oct 27, 2025 |
| UBS | Peter Grom | $176 | $150.92 | +18.4% | Oct 8, 2025 |
| Barclays | Lauren Lieberman | $153 | $153.65 | +2.9% | Oct 1, 2025 |
| Barclays | Analyst unavailable | $164 | $152.88 | +10.3% | Jul 31, 2025 |
| UBS | Peter Grom | $180 | $154.94 | +21.1% | Jul 30, 2025 |
| Redburn Partners | Edward Lewis | $161 | $159.98 | +8.3% | May 1, 2025 |
| Morgan Stanley | Dara Mohsenian | $180 | $160.06 | +21.1% | Apr 25, 2025 |
| Barclays | Lauren Lieberman | $159 | $164.74 | +7.0% | Jan 23, 2025 |
| Jefferies | Kaumil Gajrawala | $174 | $175.68 | +17.1% | Dec 5, 2024 |
| Stifel Nicolaus | Mark Astrachan | $167 | $176.28 | +12.4% | Nov 22, 2024 |
| Truist Financial | Bill Chappell | $180 | $169.64 | +21.1% | Oct 21, 2024 |
| RBC Capital | Nik Modi | $164 | $169 | +10.3% | Oct 21, 2024 |
| D.A. Davidson | Linda Bolton Weiser | $160 | $169.02 | +7.6% | Oct 21, 2024 |
| Raymond James | Olivia Tong | $190 | $171.28 | +27.8% | Oct 21, 2024 |
| D.A. Davidson | Linda Bolton Weiser | $159 | $169.27 | +7.0% | Oct 9, 2024 |
| Goldman Sachs | Bonnie Herzog | $164 | $168.88 | +10.3% | Oct 4, 2024 |
| Barclays | Lauren Lieberman | $163 | $173.55 | +9.7% | Sep 30, 2024 |
| Piper Sandler | Korinne Wolfmeyer | $174 | $173.77 | +17.1% | Sep 23, 2024 |
| BNP Paribas | Kevin Grundy | $192 | $177.02 | +29.2% | Sep 16, 2024 |
| Jefferies | Kaumil Gajrawala | $175 | $165.93 | +17.7% | Jul 24, 2024 |
| Stifel Nicolaus | Mark Astrachan | $161 | $167.96 | +8.3% | Jul 22, 2024 |
| Evercore ISI | Robert Ottenstein | $183 | $169.44 | +23.1% | Jul 18, 2024 |
| Deutsche Bank | Steve Powers | $176 | $168.53 | +18.4% | Jul 17, 2024 |
| BNP Paribas | Kevin Grundy | $187 | $168.26 | +25.8% | Jun 24, 2024 |
| Argus Research | Chris Graja | $185 | $162.88 | +24.5% | Apr 25, 2024 |
| Barclays | Lauren Lieberman | $170 | $160.54 | +14.4% | Apr 23, 2024 |
| Bernstein | Alexia Howard | $40 | $151.38 | -73.1% | Nov 24, 2023 |
| Morgan Stanley | Dara Mohsenian | $174 | $146.26 | +17.1% | Oct 18, 2023 |
| Raymond James | Olivia Tong | $170 | $150.25 | +14.4% | Jan 13, 2023 |
| J.P. Morgan | Analyst unavailable | $150 | $149.86 | +0.9% | Jan 13, 2023 |
| Wells Fargo | Analyst unavailable | $168 | $150.62 | +13.0% | Jan 3, 2023 |
| Deutsche Bank | Analyst unavailable | $162 | $148.47 | +9.0% | Dec 6, 2022 |
| Wells Fargo | Analyst unavailable | $155 | $140.49 | +4.3% | Nov 16, 2022 |
| Credit Suisse | Analyst unavailable | $130 | $141.66 | -12.5% | Nov 15, 2022 |
| Raymond James | Olivia Tong | $155 | $124.43 | +4.3% | Oct 12, 2022 |
| Goldman Sachs | Jason English | $143 | $124.27 | -3.8% | Oct 9, 2022 |
| Wells Fargo | Analyst unavailable | $150 | $126.25 | +0.9% | Oct 3, 2022 |
| Barclays | Lauren Lieberman | $154 | $149.81 | +3.6% | Aug 18, 2022 |
| Truist Financial | Analyst unavailable | $160 | $142.6 | +7.6% | Aug 1, 2022 |
| J.P. Morgan | Analyst unavailable | $156 | $139.77 | +5.0% | Jul 21, 2022 |
| Deutsche Bank | Analyst unavailable | $157 | $135.81 | +5.6% | Jun 21, 2022 |
| Deutsche Bank | Steve Powers | $171 | $132.36 | +15.1% | Jun 19, 2022 |
| Wells Fargo | Chris Carey | $170 | $145.46 | +14.4% | Jun 6, 2022 |
| Barclays | Analyst unavailable | $157 | $141.79 | +5.6% | May 23, 2022 |
| Credit Suisse | Kaumil Gajrawala | $150 | $161.74 | +0.9% | Apr 26, 2022 |
| Barclays | Analyst unavailable | $176 | $161.39 | +18.4% | Apr 22, 2022 |
| Deutsche Bank | Analyst unavailable | $177 | $164.54 | +19.1% | Apr 21, 2022 |
| Raymond James | Analyst unavailable | $180 | $163.65 | +21.1% | Apr 21, 2022 |
| UBS | Peter Grom | $160 | $158.52 | +7.6% | Apr 19, 2022 |
| Raymond James | Olivia Tong | $175 | $159.49 | +17.7% | Apr 11, 2022 |
| Goldman Sachs | Jason English | $173 | $155.09 | +16.4% | Apr 1, 2022 |
| Truist Financial | Bill Chappell | $175 | $150.82 | +17.7% | Mar 23, 2022 |
| UBS | Peter Grom | $163 | $162 | +9.7% | Jan 20, 2022 |
| Morgan Stanley | Dara Mohsenian | $177 | $162 | +19.1% | Jan 20, 2022 |
| Stifel Nicolaus | Mark Astrachan | $148 | $161.13 | -0.4% | Jan 19, 2022 |
| Jefferies | Kevin Grundy | $187 | $161.13 | +25.8% | Jan 19, 2022 |
| Wells Fargo | Christopher Carey | $180 | $163.33 | +21.1% | Jan 5, 2022 |
| Bank of America Securities | Bryan Spillane | $160 | $137.73 | +7.6% | Oct 5, 2021 |
| Independent Research | Lars Lusebrink | $154 | $140.79 | +3.6% | Aug 4, 2021 |
| Credit Suisse | Kaumil Gajrawala | $145 | $140.25 | -2.4% | Aug 2, 2021 |
| DZ BANK AG | Michael Pohn | $119 | $133.58 | -19.9% | Apr 21, 2021 |
Track every rating change on PG the moment it posts. Free to start.
Start free